Patents by Inventor Alexander A. Andreev-Andrievsky

Alexander A. Andreev-Andrievsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Mitochondria-Targeted Antioxidants to Treat Severe Inflammatory Conditions
    Publication number: 20230181604
    Abstract: Mitochondrially targeted antioxidants are used to prevent and treat severe inflammatory conditions including viral infection (such as COVID-19), systemic shock, trauma, burns, surgery associated with significant tissue damage, toxic damage, and damage associated with autoimmune reactions.
    Type: Application
    Filed: April 5, 2021
    Publication date: June 15, 2023
    Inventors: Maxim V. SKULACHEV, Roman ZINOVKIN, Alexander ANDREEV-ANDRIEVSKY, Maxim EGOROV, Elena KARGER, Anton PETROV, Lawrence FRIEDHOFF
  • Oral formulations of mitochondrially-targeted antioxidants and their preparation and use
    Patent number: 9572890
    Abstract: Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: February 21, 2017
    Assignee: MITOTECH SA
    Inventors: Maxim V. Skulachev, Vladimir P. Skulachev, Audrey A. Zamyatnin, Vadim N. Tashlitsky, Roman A. Zinovkin, Maxim V. Egorov, Lawrence T. Friedhoff, Olga Y. Pletushkina, Alexander A. Andreev-Andrievsky, Tatiana V. Zinevich
  • ORAL FORMULATIONS OF MITOCHONDRIALLY-TARGETED ANTIOXIDANTS AND THEIR PREPARATION AND USE
    Publication number: 20160038603
    Abstract: Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
    Type: Application
    Filed: October 20, 2015
    Publication date: February 11, 2016
    Inventors: Maxim V. Skulachev, Vladimir P. Skulachev, Audrey A. Zamyatnin, Vadim N. Tashlitsky, Roman A. Zinovkin, Maxim V. Egorov, Lawrence T. Friedhoff, Olga Y. Pletushkina, Alexander A. Andreev-Andrievsky, Tatiana V. Zinevich
  • Oral formulations of mitochondrially-targeted antioxidants and their preparation and use
    Patent number: 9192676
    Abstract: Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: November 24, 2015
    Assignee: MITOTECH SA
    Inventors: Maxim V. Skulachev, Vladimir P. Skulachev, Andrey A. Zamyatnin, Eugeny S. Efremov, Innokentiy V. Skulachev, Vadim N. Tashlitsky, Roman A. Zinovkin, Maxim V. Egorov, Lawrence T. Friedhoff, Olga Y. Pletushkina, Alexander A. Andreev-Andrievsky, Tatiana V. Zinevich
  • ORAL FORMULATIONS OF MITOCHONDRIALLY-TARGETED ANTIOXIDANTS AND THEIR PREPARATION AND USE
    Publication number: 20150025043
    Abstract: Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
    Type: Application
    Filed: June 4, 2012
    Publication date: January 22, 2015
    Applicant: Mitotech SA
    Inventors: Maxim V. Skulachev, Vladimir P. Skulachev, Andrey A. Zamyatnin, Vadim N. Tashlitsky, Roman A. Zinovkin, Maxim V. Egorov, Lawrence T. Friedhoff, Olga Y. Pletushkina, Alexander A. Andreev-Andrievsky, Tatiana V. Zinevich